Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-25-100516
Filing Date
2025-04-28
Accepted
2025-04-28 16:12:04
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-28

Document Format Files

Seq Description Document Type Size
1 ARS d898215dars.pdf ARS 4255462
  Complete submission text file 0001193125-25-100516.txt   5863119
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39617 | Film No.: 25880469
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)